Your browser doesn't support javascript.
loading
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment.
Malladi, Sameer Kumar; Singh, Randhir; Pandey, Suman; Gayathri, Savitha; Kanjo, Kawkab; Ahmed, Shahbaz; Khan, Mohammad Suhail; Kalita, Parismita; Girish, Nidhi; Upadhyaya, Aditya; Reddy, Poorvi; Pramanick, Ishika; Bhasin, Munmun; Mani, Shailendra; Bhattacharyya, Sankar; Joseph, Jeswin; Thankamani, Karthika; Raj, V Stalin; Dutta, Somnath; Singh, Ramandeep; Nadig, Gautham; Varadarajan, Raghavan.
Affiliation
  • Malladi SK; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Singh R; Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru, India.
  • Pandey S; Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru, India.
  • Gayathri S; Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru, India.
  • Kanjo K; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Ahmed S; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Khan MS; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Kalita P; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Girish N; Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru, India.
  • Upadhyaya A; Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru, India.
  • Reddy P; Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru, India.
  • Pramanick I; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Bhasin M; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Mani S; Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, India.
  • Bhattacharyya S; Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, India.
  • Joseph J; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Kerala, India.
  • Thankamani K; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Kerala, India.
  • Raj VS; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Kerala, India.
  • Dutta S; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India.
  • Singh R; Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, India.
  • Nadig G; Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru, India.
  • Varadarajan R; Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru, India; Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru, India. Electronic address: varadar@iisc.ac.in.
J Biol Chem ; 296: 100025, 2021.
Article in En | MEDLINE | ID: mdl-33154165

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Virus / Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Prognostic_studies Language: En Journal: J Biol Chem Year: 2021 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Virus / Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Prognostic_studies Language: En Journal: J Biol Chem Year: 2021 Document type: Article Affiliation country: India